Skip to main content
. Author manuscript; available in PMC: 2022 Apr 21.
Published in final edited form as: ACS Infect Dis. 2021 Feb 18;7(8):2277–2284. doi: 10.1021/acsinfecdis.0c00853

Figure 5.

Figure 5.

Structure–activity relationships of diaminoquinazoline KMT inhibitors. (A) Compound pairs with >60% similarity and >50% delta activity at 1 μM. (B) Structure–activity relationship against Babesia divergens. (C) Changes in chemical structure that confer differential activity against both species.